DNA synthesis technologies, supported by automated synthesizers, high-throughput platforms, oligonucleotide production ...

Built around the packages Sprint, Flex, and Flex+, Gene Synthesis 2.0 introduces a streamlined, intuitive ordering experience ...

PLC('4basebio' or the 'Company')4basebio Launches Enzymatic ssDNA PlatformOvercomes critical manufacturing and performance ...

The global DNA synthesis market is projected to grow from $5.7 billion in 2025 to $30.4 billion by 2035, according to a new ...

It is also driven by gene therapy expansion. The DNA synthesis market is estimated to reach $30.4b by 2035, growing at a ...

In an era when Washington seems incapable of finding common ground on virtually any issue, it’s notable to encounter a policy area where stakeholders across the political spectrum agree. Gene ...

Genetic medicines such as cell and gene therapies and mRNA vaccines offer extraordinary promise for treating a variety of diseases, including genetic disorders, cancer, and autoimmune diseases. These ...

Johnson and Alistar competed as finalists in CU Boulder’s 2025 Lab Venture Challenge where their technology generated much interest from industry leaders. Access to DNA is crucial in many branches of ...

DNA is the raw material of modern medicine yet is the only part of drug development not accessible at the lab bench. DNA synthesis, the first step in most biological workflows including gene synthesis ...